Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphate transmembrane transporter activity	SLC37A1 SLC17A7 SLC25A23 SLC17A6	2.53e-05	24	145	4	GO:0005315
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	GABRD SLC37A1 SLC25A27 SLC4A8 SLC17A7 ABCC2 SLC25A23 SLC17A6	3.61e-05	171	145	8	GO:0015103
GeneOntologyMolecularFunction	L-glutamate uniporter activity	SLC17A7 SLC17A6	1.56e-04	3	145	2	GO:0140788
GeneOntologyMolecularFunction	natriuretic peptide receptor activity	NPR1 NPR2	1.56e-04	3	145	2	GO:0016941
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC37A1 SLC25A42 SLC4A8 SLC27A6 SLC17A7 ABCC2 SLC22A20P SLC25A23 SLC17A6	2.97e-04	293	145	9	GO:0008514
GeneOntologyMolecularFunction	dolichyl-diphosphooligosaccharide-protein glycotransferase activity	STT3A STT3B	5.16e-04	5	145	2	GO:0004579
GeneOntologyMolecularFunction	oligosaccharyl transferase activity	STT3A STT3B	5.16e-04	5	145	2	GO:0004576
GeneOntologyMolecularFunction	membrane potential driven uniporter activity	SLC17A7 SLC17A6	5.16e-04	5	145	2	GO:0022810
GeneOntologyBiologicalProcess	RNA secondary structure unwinding	DHX9 AGO4 AGO3	2.66e-05	9	143	3	GO:0010501
GeneOntologyBiologicalProcess	semaphorin-plexin signaling pathway	SEMA7A PLXNB2 CRMP1 FARP2 SEMA6D	2.99e-05	52	143	5	GO:0071526
GeneOntologyBiologicalProcess	RISC complex assembly	DHX9 AGO4 AGO3	3.78e-05	10	143	3	GO:0070922
GeneOntologyCellularComponent	RISC-loading complex	DHX9 AGO4 AGO3	3.63e-05	10	143	3	GO:0070578
Domain	-	KLHL10 KLHL31 KLHL18 KLHL4	5.62e-05	27	147	4	2.130.10.80
Domain	Oligo_trans_STT3	STT3A STT3B	6.15e-05	2	147	2	IPR003674
Domain	STT3	STT3A STT3B	6.15e-05	2	147	2	PF02516
Domain	Gal_Oxidase_b-propeller	KLHL10 KLHL31 KLHL18 KLHL4	1.42e-04	34	147	4	IPR015916
Domain	ANF_RECEPTORS	NPR1 NPR2	1.84e-04	3	147	2	PS00458
Domain	ANPR/GUC	NPR1 NPR2	1.84e-04	3	147	2	IPR001170
Domain	Nebulin	NEBL NEB	3.65e-04	4	147	2	PF00880
Domain	NEBULIN	NEBL NEB	3.65e-04	4	147	2	PS51216
Domain	NEBU	NEBL NEB	3.65e-04	4	147	2	SM00227
Domain	Nebulin	NEBL NEB	3.65e-04	4	147	2	IPR013998
Domain	Argonaute_N	AGO4 AGO3	3.65e-04	4	147	2	IPR032474
Domain	Argonaute_Mid_dom	AGO4 AGO3	3.65e-04	4	147	2	IPR032473
Domain	ArgoL2	AGO4 AGO3	3.65e-04	4	147	2	IPR032472
Domain	Nebulin_repeat	NEBL NEB	3.65e-04	4	147	2	IPR000900
Domain	ArgoN	AGO4 AGO3	3.65e-04	4	147	2	PF16486
Domain	ArgoMid	AGO4 AGO3	3.65e-04	4	147	2	PF16487
Domain	ArgoL2	AGO4 AGO3	3.65e-04	4	147	2	PF16488
Domain	DUF1785	AGO4 AGO3	6.06e-04	5	147	2	SM01163
Domain	-	SLC25A27 SLC25A42 SLC25A20 SLC25A23	8.00e-04	53	147	4	1.50.40.10
Domain	Mito_carr	SLC25A27 SLC25A42 SLC25A20 SLC25A23	8.00e-04	53	147	4	PF00153
Domain	SOLCAR	SLC25A27 SLC25A42 SLC25A20 SLC25A23	8.00e-04	53	147	4	PS50920
Domain	Mitochondrial_sb/sol_carrier	SLC25A27 SLC25A42 SLC25A20 SLC25A23	8.00e-04	53	147	4	IPR018108
Domain	Mt_carrier_dom	SLC25A27 SLC25A42 SLC25A20 SLC25A23	8.00e-04	53	147	4	IPR023395
Domain	Calponin_repeat	TAGLN CNN1	9.04e-04	6	147	2	IPR000557
Domain	E1_dh	BCKDHA DHTKD1	9.04e-04	6	147	2	PF00676
Domain	Calponin	TAGLN CNN1	9.04e-04	6	147	2	PF00402
Domain	DH_E1	BCKDHA DHTKD1	9.04e-04	6	147	2	IPR001017
Domain	ArgoL1	AGO4 AGO3	9.04e-04	6	147	2	PF08699
Domain	ArgoL1	AGO4 AGO3	9.04e-04	6	147	2	IPR014811
Domain	CALPONIN_1	TAGLN CNN1	9.04e-04	6	147	2	PS01052
Domain	CALPONIN_2	TAGLN CNN1	9.04e-04	6	147	2	PS51122
Domain	Kelch	KLHL10 KLHL31 KLHL18 KLHL4	1.12e-03	58	147	4	SM00612
Domain	Gal_Oxase/kelch_b-propeller	KLHL10 KLHL31 KLHL18 KLHL4	1.20e-03	59	147	4	IPR011043
Domain	GPCR_kinase	GRK4 GRK5	1.26e-03	7	147	2	IPR000239
Domain	BACK	KLHL10 KLHL31 KLHL18 KLHL4	1.28e-03	60	147	4	SM00875
Domain	Aden_trnslctor	SLC25A27 SLC25A20 SLC25A23	1.35e-03	28	147	3	IPR002113
Domain	BACK	KLHL10 KLHL31 KLHL18 KLHL4	1.36e-03	61	147	4	IPR011705
Domain	BACK	KLHL10 KLHL31 KLHL18 KLHL4	1.36e-03	61	147	4	PF07707
Domain	SH3	TNK1 ABI1 NEBL RUSC1 NEB SH3RF2 PLCG2	1.63e-03	216	147	7	SM00326
Domain	SH3	TNK1 ABI1 NEBL RUSC1 NEB SH3RF2 PLCG2	1.63e-03	216	147	7	PS50002
Domain	PIWI	AGO4 AGO3	1.67e-03	8	147	2	PS50822
Domain	Piwi	AGO4 AGO3	1.67e-03	8	147	2	SM00950
Domain	Piwi	AGO4 AGO3	1.67e-03	8	147	2	PF02171
Domain	Piwi	AGO4 AGO3	1.67e-03	8	147	2	IPR003165
Domain	SH3_domain	TNK1 ABI1 NEBL RUSC1 NEB SH3RF2 PLCG2	1.81e-03	220	147	7	IPR001452
Domain	Semap_dom	SEMA7A PLXNB2 SEMA6D	1.83e-03	31	147	3	IPR001627
Domain	SEMA	SEMA7A PLXNB2 SEMA6D	1.83e-03	31	147	3	PS51004
Domain	Sema	SEMA7A PLXNB2 SEMA6D	1.83e-03	31	147	3	SM00630
Domain	Sema	SEMA7A PLXNB2 SEMA6D	1.83e-03	31	147	3	PF01403
Domain	SH3_1	ABI1 NEBL RUSC1 NEB SH3RF2 PLCG2	1.91e-03	164	147	6	PF00018
Domain	Plexin_repeat	SEMA7A PLXNB2 SEMA6D	2.00e-03	32	147	3	IPR002165
Domain	PSI	SEMA7A PLXNB2 SEMA6D	2.00e-03	32	147	3	PF01437
Domain	PAZ	AGO4 AGO3	2.14e-03	9	147	2	PS50821
Domain	PAZ	AGO4 AGO3	2.14e-03	9	147	2	SM00949
Domain	PAZ	AGO4 AGO3	2.14e-03	9	147	2	PF02170
Domain	PAZ_dom	AGO4 AGO3	2.14e-03	9	147	2	IPR003100
Domain	Kelch_1	KLHL10 KLHL31 KLHL18 KLHL4	2.26e-03	70	147	4	PF01344
Domain	Kelch_1	KLHL10 KLHL31 KLHL18 KLHL4	2.26e-03	70	147	4	IPR006652
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	FLNB SLC25A20 EMC1 MAOA SEMA7A SPEG SEC11C RPS19 BCKDHA MCCC1 ITGAV PLXNB2 DHRS1 STT3A STT3B YARS2 DNAJA3 NDUFA13 LMF2 SEC16A LTBP1 SNRNP200 HDAC1	5.52e-08	1451	148	23	30550785
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	DIP2B ABI1 SLC4A8 COL17A1 RHBDF1 CARMIL1 PAK6 STT3B FARP2 LLGL1 GPR158 PKP2 ABCC2	1.07e-06	569	148	13	30639242
Pubmed	A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III.	DCAF1 GALK1 EMC1 RBM4B BIRC6 STT3A STT3B YARS2 FARP2 TBCB NDUFA13 LMF2 LLGL1 TBR1	1.53e-06	686	148	14	28380382
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	ERC1 RPS19 PLXNB2 DHRS1 STT3A STT3B DHX9 LMF2 PKP2 SNRNP200	5.14e-06	375	148	10	32788342
Pubmed	CRMP2 mediates Sema3F-dependent axon pruning and dendritic spine remodeling.	CRMP1 SLC17A7 SLC17A6	6.23e-06	9	148	3	31919978
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	DIP2B ERC1 ADGRB2 RUSC1 PLXNB2 DNAH14 YARS2 IFNAR2 SEMA6D TRMT44 P2RY2 TMPRSS3 CIZ1 HDAC1 ALG13	1.04e-05	925	148	15	28986522
Pubmed	Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.	SLC25A27 SLC25A42 SLC25A20 HTRA2 BCKDHA MCCC1 DHRS1 YARS2 DNAJA3 NDUFA13 AGXT MCAT FH DHTKD1 SLC25A23	1.05e-05	926	148	15	20877624
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	HDAC11 FLNB ABI1 VWF ERC1 CARMIL1 LRRC49 RPS19 BCAN CRMP1 DHX9 NDUFA13 SEC16A SLC17A7 MCAT FH SLC25A23 SNRNP200 CEP170B	1.14e-05	1431	148	19	37142655
Pubmed	Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.	ABI1 VWF MOAP1 CRMP1 LLGL1 LTBP1	1.19e-05	118	148	6	21078624
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	FLNB ERC1 LRRC49 UBR4 RUSC1 MCCC1 BIRC6 ZMIZ2 SEC16A HDAC1	1.32e-05	418	148	10	34709266
Pubmed	Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome.	PCDH20 SLC17A7 SLC17A6	1.62e-05	12	148	3	27693255
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FLNB UBR4 RPS19 BIRC6 DNAH14 SLC5A2 DHX9 MST1 FREM2 TBR1 SNRNP200 FBXO34 HDAC1	1.71e-05	736	148	13	29676528
Pubmed	Induction of vitronectin and integrin alphav in the retina after optic nerve injury.	VTN ITGAV	1.80e-05	2	148	2	16479252
Pubmed	Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites.	SLC17A7 SLC17A6	1.80e-05	2	148	2	15118123
Pubmed	The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.	NPR1 NPR2	1.80e-05	2	148	2	30696704
Pubmed	GRIM-19 associates with the serine protease HtrA2 for promoting cell death.	HTRA2 NDUFA13	1.80e-05	2	148	2	17297443
Pubmed	Transiently increased colocalization of vesicular glutamate transporters 1 and 2 at single axon terminals during postnatal development of mouse neocortex: a quantitative analysis with correlation coefficient.	SLC17A7 SLC17A6	1.80e-05	2	148	2	18028110
Pubmed	Chimeric natriuretic peptide ACNP stimulates both natriuretic peptide receptors, the NPRA and NPRB.	NPR1 NPR2	1.80e-05	2	148	2	23186809
Pubmed	Expression of vesicular glutamate transporters type 1 and 2 in sensory and autonomic neurons innervating the mouse colorectum.	SLC17A7 SLC17A6	1.80e-05	2	148	2	21800314
Pubmed	[Expression of Calponin-1 and Transgelin in human uterine smooth muscles in non-labor and labor situation].	TAGLN CNN1	1.80e-05	2	148	2	21051832
Pubmed	ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.	NPR1 NPR2	1.80e-05	2	148	2	21828054
Pubmed	Mutations in STT3A and STT3B cause two congenital disorders of glycosylation.	STT3A STT3B	1.80e-05	2	148	2	23842455
Pubmed	Inhibitory effects of two G protein-coupled receptor kinases on the cell surface expression and signaling of the human adrenomedullin receptor.	GRK4 GRK5	1.80e-05	2	148	2	26820533
Pubmed	Porcine natriuretic peptide type B (pNPPB) maintains mouse oocyte meiotic arrest via natriuretic peptide receptor 2 (NPR2) in cumulus cells.	NPR1 NPR2	1.80e-05	2	148	2	24615855
Pubmed	Quantitative glycoproteomics reveals new classes of STT3A- and STT3B-dependent N-glycosylation sites.	STT3A STT3B	1.80e-05	2	148	2	31296534
Pubmed	Vasonatrin peptide stimulates both of the natriuretic peptide receptors, NPRA and NPRB.	NPR1 NPR2	1.80e-05	2	148	2	24699414
Pubmed	Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.	NPR1 NPR2	1.80e-05	2	148	2	22133375
Pubmed	Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.	SLC17A7 SLC17A6	1.80e-05	2	148	2	18155679
Pubmed	Differences in the amount of lipolysis induced by atrial natriuretic peptide in small and large adipocytes.	NPR1 LIPE	1.80e-05	2	148	2	18383440
Pubmed	The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migration.	ITGAV P2RY2	1.80e-05	2	148	2	16186116
Pubmed	Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury.	SLC17A7 SLC17A6	1.80e-05	2	148	2	17577523
Pubmed	Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain.	NPR1 NPR2	1.80e-05	2	148	2	22949736
Pubmed	Enhanced expression of natriuretic peptide receptor A and B in neutrophils of culprit lesions in patients with acute myocardial infarction.	NPR1 NPR2	1.80e-05	2	148	2	28765884
Pubmed	ATP-independent activation of natriuretic peptide receptors.	NPR1 NPR2	1.80e-05	2	148	2	15911610
Pubmed	Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.	SLC17A7 SLC17A6	1.80e-05	2	148	2	19839996
Pubmed	Contribution of the LIM domain and nebulin-repeats to the interaction of Lasp-2 with actin filaments and focal adhesions.	NEBL NEB	1.80e-05	2	148	2	19851499
Pubmed	Haploinsufficiency of VGluT1 but not VGluT2 impairs extinction of spatial preference and response suppression.	SLC17A7 SLC17A6	1.80e-05	2	148	2	23396167
Pubmed	Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning.	SLC17A7 SLC17A6	1.80e-05	2	148	2	19574394
Pubmed	Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter.	SLC17A7 SLC17A6	1.80e-05	2	148	2	10820226
Pubmed	Disruption of VGLUT1 in Cholinergic Medial Habenula Projections Increases Nicotine Self-Administration.	SLC17A7 SLC17A6	1.80e-05	2	148	2	34876472
Pubmed	Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity.	SLC17A7 SLC17A6	1.80e-05	2	148	2	21435559
Pubmed	Vesicular glutamate transporters VGLUT1 and VGLUT2 in the developing mouse barrel cortex.	SLC17A7 SLC17A6	1.80e-05	2	148	2	17289331
Pubmed	Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.	VTN ITGAV	1.80e-05	2	148	2	18781095
Pubmed	Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse.	SLC17A7 SLC17A6	1.80e-05	2	148	2	18181146
Pubmed	Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP.	NPR1 NPR2	1.80e-05	2	148	2	17848634
Pubmed	The middle X residue influences cotranslational N-glycosylation consensus site skipping.	STT3A STT3B	1.80e-05	2	148	2	25029371
Pubmed	Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.	SLC17A7 SLC17A6	1.80e-05	2	148	2	17531353
Pubmed	Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation.	VTN ITGAV	1.80e-05	2	148	2	19998373
Pubmed	Proteome and Glycoproteome Analyses Reveal the Protein N-Linked Glycosylation Specificity of STT3A and STT3B.	STT3A STT3B	1.80e-05	2	148	2	36139350
Pubmed	TOPK Affects Autophagy of Skin Squamous Cell Carcinoma by Regulating NF-KB Pathway through HDAC1.	PBK HDAC1	1.80e-05	2	148	2	35756488
Pubmed	Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.	NPR1 NPR2	1.80e-05	2	148	2	20977274
Pubmed	Altered vesicular glutamate transporter distributions in the mouse cochlear nucleus following cochlear insult.	SLC17A7 SLC17A6	1.80e-05	2	148	2	26705736
Pubmed	Adhesion of human ovarian adenocarcinoma IGROV1 cells to endothelial cells is partly mediated by the alphav integrins-vitronectin adhesive system and induces an alteration of endothelial integrity.	VTN ITGAV	1.80e-05	2	148	2	15914035
Pubmed	Mammalian STT3A/B oligosaccharyltransferases segregate N-glycosylation at the translocon from lipid-linked oligosaccharide hydrolysis.	STT3A STT3B	1.80e-05	2	148	2	30181269
Pubmed	Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity.	SLC17A7 SLC17A6	1.80e-05	2	148	2	19171494
Pubmed	Phospholipase Cgamma2 contributes to stable thrombus formation on VWF.	VWF PLCG2	1.80e-05	2	148	2	15327970
Pubmed	Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain.	SLC17A7 SLC17A6	1.80e-05	2	148	2	16217795
Pubmed	The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.	NPR1 NPR2	1.80e-05	2	148	2	21366551
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	DIP2B EMC1 MAOA HTRA2 LRRC49 UBR4 BCKDHA PLXNB2 BIRC6 STT3A STT3B YARS2 DHX9 DNAJA3 NDUFA13 LMF2 SEC16A DHTKD1 ALG13	2.10e-05	1496	148	19	32877691
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DCAF1 FLNB STT3B DHX9 SEC16A TBR1 SNRNP200	2.69e-05	202	148	7	33005030
Pubmed	Update on the Kelch-like (KLHL) gene family.	KLHL10 KLHL31 KLHL18 KLHL4	2.82e-05	41	148	4	23676014
Pubmed	Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.	FLNB NEBL NEB TRIM55	2.82e-05	41	148	4	18157088
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	DIP2B ABI1 EMC1 MAOA NEBL ERC1 RPS19 STT3B TBCB LLGL1 TAGLN	2.91e-05	558	148	11	35063084
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	FLNB ABI1 EMC1 SLC4A8 ERC1 UBR4 ADGRB2 MCCC1 DHRS1 BIRC6 SHISA7 STT3B TBCB DNAJA3 GPR158 CEP170B	3.01e-05	1139	148	16	36417873
Pubmed	Rescue of neuropsychiatric phenotypes in a mouse model of 16p11.2 duplication syndrome by genetic correction of an epilepsy network hub.	ABI1 ADAM23 ITGAV NDUFA13 LIPE PRRT3 SLC17A7	4.00e-05	215	148	7	36808153
Pubmed	Tbr2 deficiency in mitral and tufted cells disrupts excitatory-inhibitory balance of neural circuitry in the mouse olfactory bulb.	SLC17A7 TBR1 SLC17A6	4.06e-05	16	148	3	22745484
Pubmed	Thalamo-cortical axons regulate the radial dispersion of neocortical GABAergic interneurons.	SLC17A7 TBR1 SLC17A6	4.06e-05	16	148	3	27935475
Pubmed	A mitochondrial protein compendium elucidates complex I disease biology.	SLC25A27 SLC25A42 SLC25A20 MAOA HTRA2 BCKDHA MCCC1 DHRS1 YARS2 DNAJA3 NDUFA13 AGXT MCAT FH SLC25A23	4.33e-05	1047	148	15	18614015
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	GABRD NPR1 NPR2 MAOA FAAH SLC17A7 PLCG2 SLC17A6	4.63e-05	300	148	8	19086053
Pubmed	Sequential generation of olfactory bulb glutamatergic neurons by Neurog2-expressing precursor cells.	SLC17A7 TBR1 SLC17A6	4.91e-05	17	148	3	21466690
Pubmed	Vesicular glutamate transporters use flexible anion and cation binding sites for efficient accumulation of neurotransmitter.	SLC17A7 SLC17A6	5.38e-05	3	148	2	25433636
Pubmed	Diverse glutamatergic inputs target spines expressing M1 muscarinic receptors in the basolateral amygdala: An ultrastructural analysis.	SLC17A7 SLC17A6	5.38e-05	3	148	2	31348911
Pubmed	The alphavbeta5 integrin functions as an endocytic receptor for vitronectin.	VTN ITGAV	5.38e-05	3	148	2	9443892
Pubmed	A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK-Ialpha does not regulate NPR-A.	NPR1 NPR2	5.38e-05	3	148	2	16430226
Pubmed	Glutamatergic and GABAergic innervation of human gonadotropin-releasing hormone-I neurons.	SLC17A7 SLC17A6	5.38e-05	3	148	2	22510271
Pubmed	Expression of VGLUTs contributes to degeneration and acquisition of learning and memory.	SLC17A7 SLC17A6	5.38e-05	3	148	2	21295146
Pubmed	Skeletal muscle derived Musclin protects the heart during pathological overload.	NPR1 NPR2	5.38e-05	3	148	2	35013221
Pubmed	STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion.	STT3A STT3B	5.38e-05	3	148	2	29765039
Pubmed	Novel candidate genes putatively involved in stress fracture predisposition detected by whole-exome sequencing.	GRK4 NEB	5.38e-05	3	148	2	25023003
Pubmed	Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells.	VTN ITGAV	5.38e-05	3	148	2	23722547
Pubmed	G protein-coupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells.	GRK4 GRK5	5.38e-05	3	148	2	9092566
Pubmed	Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.	ELK1 HDAC1	5.38e-05	3	148	2	11283259
Pubmed	Vesicular Glutamate Transporters (SLCA17 A6, 7, 8) Control Synaptic Phosphate Levels.	SLC17A7 SLC17A6	5.38e-05	3	148	2	33440152
Pubmed	GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.	GRK4 GRK5	5.38e-05	3	148	2	19842931
Pubmed	Differential maturation of vesicular glutamate and GABA transporter expression in the mouse auditory forebrain during the first weeks of hearing.	SLC17A7 SLC17A6	5.38e-05	3	148	2	26159773
Pubmed	Docking and homology modeling explain inhibition of the human vesicular glutamate transporters.	SLC17A7 SLC17A6	5.38e-05	3	148	2	17660252
Pubmed	Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene.	SLC17A7 SLC17A6	5.38e-05	3	148	2	29920554
Pubmed	Heparin binding domain in vitronectin is required for oligomerization and thus enhances integrin mediated cell adhesion and spreading.	VTN ITGAV	5.38e-05	3	148	2	20600001
Pubmed	Solid-phase von Willebrand factor contains a conformationally active RGD motif that mediates endothelial cell adhesion through the alpha v beta 3 receptor.	VWF ITGAV	5.38e-05	3	148	2	7505120
Pubmed	Identification by shotgun sequencing, genomic organization, and functional analysis of a fourth arylsulfatase gene (ARSF) from the Xp22.3 region.	ARSL ARSF	5.38e-05	3	148	2	9192838
Pubmed	ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism.	ADAM23 ITGAV	5.38e-05	3	148	2	10749942
Pubmed	Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.	SLC17A7 SLC17A6	5.38e-05	3	148	2	26332770
Pubmed	Lack of evidence for vesicular glutamate transporter expression in mouse astrocytes.	SLC17A7 SLC17A6	5.38e-05	3	148	2	23467360
Pubmed	Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms.	STT3A STT3B	5.38e-05	3	148	2	19167329
Pubmed	Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain.	SLC17A7 SLC17A6	5.38e-05	3	148	2	17108179
Pubmed	Regulation of natriuretic peptides postprandially in vivo and of their receptors in adipocytes by fatty acids in vitro.	NPR1 NPR2	5.38e-05	3	148	2	29409758
Pubmed	Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress.	VWF ITGAV	5.38e-05	3	148	2	18927433
Pubmed	Chromosomal distribution of three members of the human natriuretic peptide receptor/guanylyl cyclase gene family.	NPR1 NPR2	5.38e-05	3	148	2	1979052
Pubmed	Pericyte-to-endothelial cell signaling via vitronectin-integrin regulates blood-CNS barrier.	VTN ITGAV	5.38e-05	3	148	2	35294899
Pubmed	P2Y4 Nucleotide Receptor in Neuronal Precursors Induces Glutamatergic Subtype Markers in Their Descendant Neurons.	SLC17A7 SLC17A6	5.38e-05	3	148	2	26972684
Cytoband	1p34	AGO4 AGO3 HDAC1	1.52e-04	32	148	3	1p34
GeneFamily	Solute carriers	SLC37A1 SLC25A27 SLC25A42 SLC25A20 SLC4A8 SLC27A6 SLC48A1 SLC5A2 SLC17A7 SLC22A20P SLC25A23 SLC17A6	3.47e-06	395	106	12	752
GeneFamily	STT3 oligosaccharyltransferase catalytic subunits\|Oligosaccharyltransferase complex subunits	STT3A STT3B	3.41e-05	2	106	2	444
GeneFamily	Kelch like\|BTB domain containing	KLHL10 KLHL31 KLHL18 KLHL4	1.05e-04	42	106	4	617
GeneFamily	Guanylate cyclase receptors	NPR1 NPR2	7.01e-04	7	106	2	343
GeneFamily	Argonaute/PIWI family	AGO4 AGO3	9.32e-04	8	106	2	408
GeneFamily	Oligosaccharyltransferase complex subunits	STT3A STT3B	2.16e-03	12	106	2	445
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPEG CYP27C1 ITGAV SEMA6D LTBP1 TAGLN CNN1 SAMD4A	2.02e-07	185	148	8	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VTN GRK4 NEB PKHD1L1 MST1 PRRT3 CLRN2 KLHL4	3.14e-07	196	148	8	96e5c6d155273e82ebafa180df8bb589c3e3e54e
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VTN GRK4 NEB PKHD1L1 MST1 PRRT3 CLRN2 KLHL4	3.14e-07	196	148	8	ce13af36fc2932e8125013041742593ff3d07e86
ToppCell	droplet-Heart-4Chambers-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB NPR1 VWF RUSC1 LIPE LRP5 NOTCH4	1.86e-06	173	148	7	9a04271c51fae34f547db3206f9ff5857686e45c
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC25A42 FAAH MST1 PKP2 ABCC2 DHTKD1 SLC25A23	2.61e-06	182	148	7	770ce9f3f4538d0181a0181543841bc964c68274
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRD ERC1 PCDH20 KLHL31 TAGLN SDCBP2 CNN1	2.61e-06	182	148	7	dfde2d9950f445c6c936ac828f7210de87bb45ec
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRD ERC1 PCDH20 KLHL31 TAGLN SDCBP2 CNN1	2.61e-06	182	148	7	52274af3136d4fd4a495f5882618444661421f0f
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC25A42 FAAH MST1 PKP2 ABCC2 DHTKD1 SLC25A23	2.61e-06	182	148	7	77ab860e2add49dad0c1ffbfc64278ad499dfbd5
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC25A42 FAAH MST1 PKP2 ABCC2 DHTKD1 SLC25A23	2.61e-06	182	148	7	4921c7d5687cc79f896b39753bb621d7e3d2972f
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC25A42 FAAH FARP2 MST1 PKP2 ABCC2 DHTKD1	2.71e-06	183	148	7	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN FSD2 NEB SHISA7 KLHL31 TAGLN CNN1	2.71e-06	183	148	7	6f5dbac2748f50105f0f548d189c42ef14287019
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	NEBL ITGAV PXDNL PKP2 LTBP1 CNN1 SAMD4A	2.81e-06	184	148	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN NEBL HSPA12B P2RY2 LTBP1 SDCBP2 NOTCH4	3.23e-06	188	148	7	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPEG SEMA6D PXDNL LTBP1 TAGLN CNN1 KLHL4	3.23e-06	188	148	7	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SPEG ITGA10 PXDNL LTBP1 TAGLN CNN1 KLHL4	3.47e-06	190	148	7	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NPR1 VWF HSPA12B SH3RF2 TDRD10 NOTCH4 KLHL4	3.72e-06	192	148	7	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SEC11C SLC48A1 DNAH14 FAT2 CLRN2	5.51e-06	76	148	5	efbbbf91bca35720d8ecddb076f2c9f4de25e44d
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SEC11C SLC48A1 DNAH14 FAT2 CLRN2	5.51e-06	76	148	5	254d18bece2676faa4bbeb8d48b1d327ab3c2215
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tfh\|GI_small-bowel / Manually curated celltypes from each tissue	ADAM23 ADGRB2 DHRS1 SLC5A2 LLGL1 LTBP1	5.81e-06	134	148	6	bf94ce5edde8912a27010e229c313d8102d6de62
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TNK1 SLC27A6 MOAP1 TMPRSS3 BFSP2	1.01e-05	86	148	5	db67c05c876a5649371c0dc6c941cc371bc2feb8
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TNK1 SLC27A6 MOAP1 TMPRSS3 BFSP2	1.01e-05	86	148	5	2778446e035c5585bce28ed0ef93b87b6ad90c6e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	B4GALT2 SEMA7A CARMIL1 PKHD1L1 LRP5 KLHL4	1.34e-05	155	148	6	881422c57d230c0e2e5f9098ab888caa94ca61aa
ToppCell	COVID-19-lung-Mesothelial\|lung / Disease (COVID-19 only), tissue and cell type	SPEG PKHD1L1 KLHL31 MST1 SEMA6D PKP2	1.39e-05	156	148	6	e1f563869b3bf997eaa2e756e31b53db1a478903
ToppCell	Healthy_Control-Lymphoid-Plasma\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	SLC25A42 SEMA7A RBM4B GRK5 PKHD1L1 PKP2	1.78e-05	163	148	6	2913ccdd4613472cd82077d4993e1d9f8b223398
ToppCell	Healthy_Control-Lymphoid-Plasma-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	SLC25A42 SEMA7A RBM4B GRK5 PKHD1L1 PKP2	1.78e-05	163	148	6	b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCell	control-Plasmablast\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	B4GALT2 PBK SEC11C RFX8 PKHD1L1 BSCL2	1.90e-05	165	148	6	61063e0ce61bc92d5d1093be8279af03f650720b
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FSD2 NEB KLHL31 GPR158 SH3RF2 TRIM55	2.04e-05	167	148	6	d78356bf0c473816dbabaee51984940bd822f84e
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	SPEG ADGRB2 ITGA10 LTBP1 CNN1 CBX8	2.04e-05	167	148	6	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	normal_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	VTN COL17A1 LGALS12 KLHL31 MST1 TMPRSS3	2.04e-05	167	148	6	892a2dc83ab5de5a1016402f8e95d2aabf651326
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARMIL1 GRK5 FARP2 TMPRSS3 ZFHX2 PLCG2	2.11e-05	168	148	6	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	facs-Marrow-Granulocytes-24m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HDAC11 FSD2 ITGAV PLXNB2 PKP2 LTBP1	2.25e-05	170	148	6	8d3c51364a332020810836e2055c60893c10d7f3
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPEG KLHL31 TRIM55 TAGLN SLC25A23 CNN1	2.25e-05	170	148	6	cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPEG KLHL31 TRIM55 TAGLN SLC25A23 CNN1	2.25e-05	170	148	6	da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	NEBL CYP27C1 ITGAV IFNAR2 FAT2 FBXO34	2.33e-05	171	148	6	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL FSD2 NEB KLHL31 AGXT TRIM55	2.41e-05	172	148	6	ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL FSD2 NEB KLHL31 AGXT TRIM55	2.41e-05	172	148	6	bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT4 GRK5 PBK PAK6 CRMP1 ELK1	2.49e-05	173	148	6	766e712e4db440468a32971459c1d3354add611f
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNB NPR1 VWF SETD6 LLGL1 PLCG2	2.49e-05	173	148	6	4968712af1cca8c932abd3323631d7dcaffd4a66
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT4 GRK5 PBK PAK6 CRMP1 ELK1	2.49e-05	173	148	6	40ef91afb366e87b5ba2951d2578ebfe04d042c0
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NEBL KLHL31 TRIM55 PKP2 LTBP1 CNN1	2.74e-05	176	148	6	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNB NPR1 VWF SEMA7A HSPA12B NOTCH4	2.74e-05	176	148	6	96779273b94345250cf53ba671203345b43d9e00
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NEBL KLHL31 PXDNL TRIM55 PKP2 LTBP1	3.20e-05	181	148	6	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC37A1 NEBL SLC27A6 SLC48A1 CRMP1 TRIM55	3.41e-05	183	148	6	83592c332b1e82673f993d37c7f480befdc3dcda
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ITGA10 DNAH14 STT3A SH3RF2 TRIM55 PLCG2	3.41e-05	183	148	6	dd15e1463a0d57d14800de0df0645c81c56926ae
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ITGA10 DNAH14 STT3A SH3RF2 TRIM55 PLCG2	3.41e-05	183	148	6	8ace19c38b89556d2504258a63aa5a2b14f5cd36
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNK1 ITGA10 SEMA6D LTBP1 TAGLN CNN1	3.62e-05	185	148	6	7b1c5d99bd7a6e148524029758cee244a17f5d09
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNK1 ITGA10 SEMA6D LTBP1 TAGLN CNN1	3.62e-05	185	148	6	e9033a03d574956cf3ae228740b3166e40a6397f
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNK1 ITGA10 SEMA6D LTBP1 TAGLN CNN1	3.62e-05	185	148	6	578f12c6b2e33d09598dc8e022a20c8555d1325c
ToppCell	droplet-Bladder-Unstain-18m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN SLC4A8 PCDH20 LIPE SEMA6D NOTCH4	3.73e-05	186	148	6	e3a14f3ccadbf3211822c67b8956ee01f563307a
ToppCell	droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN SLC4A8 SPEG PRRT3 TAGLN CNN1	3.84e-05	187	148	6	59313a47a6012b2413d7d3673bb05fb7e49fd88f
ToppCell	droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN SLC4A8 SPEG PRRT3 TAGLN CNN1	3.84e-05	187	148	6	2591fe1552cd10925ad1d8d1f062a057ce6bdad9
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 NEBL HSPA12B SLC48A1 TDRD10 NOTCH4	3.84e-05	187	148	6	d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FLNB NPR1 VWF PLCG2 SDCBP2 NOTCH4	3.84e-05	187	148	6	66ebe1788d51b3e17bec6cdb219f709756b4e530
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	NEBL CARMIL1 GRK5 SEMA6D SH3RF2 SAMD4A	3.84e-05	187	148	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	NEBL ADAM23 FSD2 KLHL31 SH3RF2 PKP2	3.84e-05	187	148	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HDAC11 VTN SLC4A8 SPEG TAGLN CNN1	3.96e-05	188	148	6	a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN SLC4A8 SPEG KLHL31 TAGLN CNN1	3.96e-05	188	148	6	d534ed9870405a3c1075962308f72b460aed17bf
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	NEBL ADAM23 FSD2 KLHL31 SH3RF2 PKP2	4.08e-05	189	148	6	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SPEG SEMA6D LTBP1 TAGLN CNN1 KLHL4	4.08e-05	189	148	6	da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG ADGRB2 SH3RF2 TAGLN SLC25A23 CNN1	4.08e-05	189	148	6	4dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG ADGRB2 SH3RF2 TAGLN SLC25A23 CNN1	4.08e-05	189	148	6	0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	NEBL ADAM23 FSD2 KLHL31 PKP2 SAMD4A	4.20e-05	190	148	6	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	SPEG CYP27C1 SEMA6D LTBP1 TAGLN CNN1	4.20e-05	190	148	6	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF SEMA7A HSPA12B LIPE NOTCH4 KLHL4	4.20e-05	190	148	6	2655df8c0883dd811fa7617301f9c4b0a4dd55ec
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	VWF ADAM23 GRK5 HSPA12B LTBP1 NOTCH4	4.32e-05	191	148	6	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	NEBL FSD2 KLHL31 PXDNL PKP2 SAMD4A	4.32e-05	191	148	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Control-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	VWF MAOA GRK5 ITGA10 HSPA12B NOTCH4	4.32e-05	191	148	6	c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	VWF MAOA GRK5 ITGA10 HSPA12B NOTCH4	4.32e-05	191	148	6	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL SEMA7A HSPA12B LTBP1 SDCBP2 NOTCH4	4.32e-05	191	148	6	b9ae5af426e7a1f2652a47700bb168371bd2dec6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG CARMIL1 GRK5 LTBP1 TAGLN CNN1	4.45e-05	192	148	6	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG FSD2 PAK6 KLHL31 FREM2 SLC17A7	4.45e-05	192	148	6	f6a4e348406a852ace9fb21db8fbdff539217645
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPEG ITGA10 LTBP1 TAGLN CNN1 SAMD4A	4.45e-05	192	148	6	26d9207e72bbef5e0046de511e2c9ff752b726f3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPEG CARMIL1 GRK5 LTBP1 TAGLN CNN1	4.45e-05	192	148	6	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VTN SPEG SH3RF2 TAGLN CNN1 SAMD4A	4.45e-05	192	148	6	2cc712186e37fb21a964c032765c36a8b4a852cf
ToppCell	droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG FSD2 PAK6 KLHL31 FREM2 SLC17A7	4.45e-05	192	148	6	1a0c25106ae08eac912a4edd5fc1a3ee776f69c2
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NPR1 VWF MAOA ITGA10 HSPA12B NOTCH4	4.58e-05	193	148	6	3f8280ef849d95b2fcea5e6824b95a07febc96d0
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB UBR4 NEB PLXNB2 SEC16A CEP170B	4.58e-05	193	148	6	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF ERC1 IFNAR2 LTBP1 NOTCH4 KLHL4	4.58e-05	193	148	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB UBR4 NEB PLXNB2 SEC16A CEP170B	4.58e-05	193	148	6	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NPR1 VWF MAOA HSPA12B CRMP1 NOTCH4	4.58e-05	193	148	6	ff6e6b825d6c88148216c601580be3c28851ab5c
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	NEBL PXDNL TRIM55 LTBP1 CNN1 SAMD4A	4.72e-05	194	148	6	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	NEBL KLHL31 TRIM55 PKP2 LTBP1 SAMD4A	4.72e-05	194	148	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VWF HSPA12B PKHD1L1 CRMP1 NOTCH4 KLHL4	4.99e-05	196	148	6	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NPR1 VWF MAOA ITGA10 HSPA12B NOTCH4	5.14e-05	197	148	6	62c0a90869431e582bb7bb329e0b0cc59123d3d1
ToppCell	mild-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	B4GALT2 ERC1 SEC11C PKHD1L1 STT3A BFSP2	5.14e-05	197	148	6	21085d5e27b5a23a241a933058bb89f8a1fcf198
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NPR1 VWF MAOA ITGA10 HSPA12B NOTCH4	5.14e-05	197	148	6	16f0eb047df9d702518f82ee99c6e7dc1350b2fb
ToppCell	metastatic_Brain-Endothelial_cells\|metastatic_Brain / Location, Cell class and cell subclass	GABRD NPR1 VWF ITGA10 HSPA12B NOTCH4	5.28e-05	198	148	6	97ef7946ef11ac93318c1dd46b548dc01e5a6aba
ToppCell	Tracheal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VWF HSPA12B PKHD1L1 TDRD10 NOTCH4 KLHL4	5.28e-05	198	148	6	77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d
ToppCell	metastatic_Brain-Endothelial_cells-Tumor_ECs\|metastatic_Brain / Location, Cell class and cell subclass	GABRD NPR1 VWF ITGA10 HSPA12B NOTCH4	5.28e-05	198	148	6	5e274f29cc796dae7d64d6035e904816c25f9914
ToppCell	mild-Plasmablast\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	B4GALT2 PBK SEC11C PKHD1L1 STT3A BFSP2	5.28e-05	198	148	6	b14b9e67815f93fac7bd8e5e6f1aa100951b4ac1
ToppCell	severe-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	B4GALT2 PBK SEC11C PKHD1L1 STT3A BFSP2	5.43e-05	199	148	6	6ee4c2e6049860071169366b7e662d5c1a3cc54b
ToppCell	Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	COL17A1 SEMA7A CYP27C1 SH3RF2 PXDNL SAMD4A	5.43e-05	199	148	6	3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NPR1 VWF MAOA ITGA10 HSPA12B NOTCH4	5.43e-05	199	148	6	c5c12c8288fe868322bae9d691b91fee953ceb3e
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	COL17A1 SEMA7A ITGAV LTBP1 TAGLN CNN1	5.43e-05	199	148	6	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Artery\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	NPR1 VWF GRK5 HSPA12B LTBP1 NOTCH4	5.58e-05	200	148	6	34b279804475ea58fbb052b96f44128c082627a9
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NPR1 VWF GRK5 HSPA12B LTBP1 NOTCH4	5.58e-05	200	148	6	8552cc7a439449b30b59760c3e8667217b9852b5
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	FLNB NPR1 VWF MAOA HSPA12B LTBP1	5.58e-05	200	148	6	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPR1 VWF GRK5 HSPA12B LTBP1 NOTCH4	5.58e-05	200	148	6	45c08f1befe78553bbadcc2fcffb6138306638f3
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	CARMIL1 HSPA12B PXDNL SLC17A7 ABCC2	5.69e-05	123	148	5	12b87d06e62f142e18424aae5c87454e78e713f0
ToppCell	Cerebellum-Neuronal-Excitatory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PCDHA11 PAK6 TRMT44 TBR1 SLC17A6	6.88e-05	128	148	5	c30ba14320e9b98c9af9e4cd5a8c55380bb9ffa9
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A	DCAF1 B3GNT4 NPR2 UBR4 NEB SLC48A1 SLC5A2 AGO4 SLC17A7 ELK1	6.07e-07	196	147	10	3933_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	RAD52 NPR1 NEBL ADAM23 GRK5 SLC5A2 LIPE ZMIZ2 SAMD4A KLHL4	6.98e-07	199	147	10	5066_UP
Drug	fullerene C60	B4GALT2 DCAF1 SLC37A1 FLNB SLC25A42 SEMA7A SETD6 PSMB9 HSPA12B SLC48A1 PLXNB2 FREM2 LLGL1 SEMA6D ARSL ZMIZ2 TMPRSS3 MAPKAPK3 LRP5 MCAT PLCG2 FH KLHL18 CNN1 HDAC1 SLC17A6	3.47e-06	1498	147	26	ctd:C069837
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; MCF7; HT_HG-U133A	TNK1 HDAC11 NPR2 MAOA ITGA10 BCAN LMF2 ZFHX2 LTBP1	5.35e-06	196	147	9	2280_DN
Drug	0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A	TNK1 NEBL GRK5 UBR4 ADGRB2 NEB AGO4 NFKBIB SLC17A7	5.57e-06	197	147	9	6389_UP
Drug	Praziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A	DCAF1 HDAC11 SLC4A8 MAOA SEMA7A NEB SLC5A2 LMF2 SLC17A7	5.57e-06	197	147	9	7228_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	EMC1 MAOA SPEG LMF2 AGO4 ZMIZ2 AGXT ZFHX2 SAMD4A	6.05e-06	199	147	9	3625_UP
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; HL60; HT_HG-U133A	TNK1 FLNB NPR1 NEBL SLC48A1 SEMA6D NFKBIB SLC17A7 SAMD4A	6.05e-06	199	147	9	3047_UP
Drug	Ac-rgds-nh2	VTN VWF ITGAV	1.44e-05	8	147	3	CID003081210
Drug	alpha-phellandrene	VTN SPEG MCAT	1.44e-05	8	147	3	CID000007460
Drug	Grgd Peptide	VTN VWF ITGAV	3.06e-05	10	147	3	CID000126679
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A	GRK4 ITGA10 AGO3 NFKBIB ELK1 TAGLN CNN1 ALG13	3.63e-05	192	147	8	2703_DN
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	EMC1 NEBL SLC48A1 ZMIZ2 NFKBIB ZFHX2 CBX8 OSGIN1	3.90e-05	194	147	8	3674_DN
Drug	alpha-pinene	SPEG MCCC1 STT3A FARP2 NFKBIB	3.96e-05	59	147	5	CID000006654
Drug	H-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A	DCAF1 EMC1 MAOA NEB ZMIZ2 SLC17A7 ELK1 SLC25A23	4.05e-05	195	147	8	5941_UP
Drug	Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A	RAD52 HDAC11 GALK1 EMC1 LRRC49 SLC48A1 LLGL1 ZFHX2	4.05e-05	195	147	8	3358_DN
Drug	Erythrityl Tetranitrate	NPR1 NPR2	4.14e-05	2	147	2	DB01613
Drug	camphene	SPEG FARP2 MCAT	4.19e-05	11	147	3	CID000006616
Drug	Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; HL60; HT_HG-U133A	RAD52 NPR2 GALK1 MAOA HTRA2 SLC48A1 LMF2 NFKBIB	4.20e-05	196	147	8	2488_DN
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	HDAC11 ADAM23 SETD6 GRK4 CRMP1 NFKBIB CNN1 CEP170B	4.20e-05	196	147	8	6744_DN
Drug	Althiazide [5588-16-9]; Down 200; 10.4uM; PC3; HT_HG-U133A	ABI1 GALK1 SLC4A8 SPEG BCAN IFNAR2 ZMIZ2 NFKBIB	4.20e-05	196	147	8	4491_DN
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A	FCRL2 COL17A1 ADGRB2 SLC48A1 FAAH ZMIZ2 ELK1 SAMD4A	4.20e-05	196	147	8	4075_UP
Drug	Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	RAD52 GRK5 FAAH FARP2 LMF2 SEMA6D ZMIZ2 CEP170B	4.35e-05	197	147	8	6095_DN
Drug	Levodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A	NPR1 SPEG SLC48A1 SLC5A2 SEMA6D PKP2 ZFHX2 SAMD4A	4.35e-05	197	147	8	4394_UP
Drug	Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A	RAD52 TNK1 MBTPS1 CARMIL1 NFKBIB ELK1 SLC25A23 SAMD4A	4.35e-05	197	147	8	3532_DN
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A	RAD52 EMC1 MAOA GRK4 BCAN SLC5A2 LMF2 AGO4	4.35e-05	197	147	8	6611_DN
Drug	Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; PC3; HT_HG-U133A	NEBL ADAM23 SPEG GRK5 ADGRB2 SLC5A2 SLC17A7 ABCC2	4.35e-05	197	147	8	5054_UP
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A	RAD52 NPR2 SLC48A1 SLC5A2 ZMIZ2 AGXT PKP2 SAMD4A	4.35e-05	197	147	8	3632_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A	NPR1 NPR2 GALK1 VWF SLC48A1 ZMIZ2 SLC17A7 LTBP1	4.51e-05	198	147	8	2929_UP
Drug	sulindac; Up 200; 100uM; MCF7; HG-U133A	DCAF1 NEBL GRK5 LMF2 SEMA6D SLC17A7 SLC25A23 CBX8	4.51e-05	198	147	8	168_UP
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A	DCAF1 RAD52 ADAM23 SPEG BCAN SLC48A1 CRMP1 ELK1	4.67e-05	199	147	8	4984_UP
Drug	Phenacetin [62-44-2]; Up 200; 22.4uM; HL60; HT_HG-U133A	NPR1 SPEG SLC5A2 SEMA6D NFKBIB LTBP1 CNN1 CBX8	4.67e-05	199	147	8	2471_UP
Drug	Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; HL60; HT_HG-U133A	NPR1 NPR2 COL17A1 NFKBIB SLC17A7 ZFHX2 ELK1 CBX8	4.67e-05	199	147	8	2498_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	DCAF1 HDAC11 EMC1 NEBL NEB CRMP1 FARP2 CBX8	4.67e-05	199	147	8	4119_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A	RAD52 NPR2 GRK5 LLGL1 ZMIZ2 NFKBIB TMPRSS3 ABCC2	4.67e-05	199	147	8	7214_UP
Drug	2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A	MAOA GRK4 NEB FAAH LMF2 NFKBIB SAMD4A OSGIN1	4.84e-05	200	147	8	6227_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; HL60; HG-U133A	DCAF1 RAD52 GRK5 YARS2 ZMIZ2 BSCL2 KLHL18 ALG13	4.84e-05	200	147	8	1570_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A	GALK1 RHBDF1 NEB LMF2 AGO4 NFKBIB LRP5 CEP170B	4.84e-05	200	147	8	1872_DN
Drug	Butacaine [149-16-6]; Up 200; 13uM; HL60; HT_HG-U133A	HDAC11 MAOA GRK4 SLC5A2 ARSL SLC17A7 TBR1 CEP170B	4.84e-05	200	147	8	2728_UP
Drug	Nesiritide	NPR1 NPR2	1.24e-04	3	147	2	DB04899
Drug	4-phenylbutylamine	NPR2 VTN MAOA MCAT SLC17A6	1.34e-04	76	147	5	CID000083242
Drug	AC1O6F66	STT3A BFSP2 CBX8	1.39e-04	16	147	3	CID006474108
Drug	oxadiazol-3-ium	NPR1 MAOA FAAH	1.39e-04	16	147	3	CID010197612
Drug	DEANO	NPR1 NPR2 SLC17A7 SLC17A6	1.69e-04	43	147	4	CID000163608
Drug	Grgds	VTN VWF SPEG ITGAV CNN1	2.03e-04	83	147	5	CID000123811
Drug	Levonordefrin [829-74-3]; Up 200; 21.8uM; PC3; HT_HG-U133A	NEBL GRK5 NEB LLGL1 AGO4 SLC17A7 TBR1	2.18e-04	187	147	7	5854_UP
Drug	Securinine [5610-40-2]; Up 200; 18.4uM; HL60; HT_HG-U133A	NPR1 COL17A1 NEBL SLC48A1 LMF2 TAGLN OSGIN1	2.33e-04	189	147	7	2729_UP
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A	RAD52 NPR2 CIZ1 ELK1 LTBP1 CBX8 OSGIN1	2.40e-04	190	147	7	3833_DN
Drug	3-O-methyl-6-deoxy-d-talose	DHX9 LRP5	2.46e-04	4	147	2	CID000150840
Drug	Rdv peptide	VTN VWF	2.46e-04	4	147	2	CID000196843
Drug	AC1L3EHA	FARP2 CNN1	2.46e-04	4	147	2	CID000139200
Drug	aThr	HTRA2 DHX9	2.46e-04	4	147	2	CID003081657
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A	GABRD RAD52 B3GNT4 SETD6 CIZ1 SLC25A23 ALG13	2.48e-04	191	147	7	2900_UP
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	NPR2 GALK1 EMC1 NEBL FAAH P2RY2 CBX8	2.48e-04	191	147	7	5204_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	HDAC11 EMC1 LMF2 ZMIZ2 NFKBIB ELK1 SAMD4A	2.64e-04	193	147	7	3973_DN
Drug	Piromidic acid [19562-30-2]; Up 200; 13.8uM; PC3; HT_HG-U133A	NPR2 COL17A1 NEBL NEB TMPRSS3 CIZ1 SLC17A7	2.73e-04	194	147	7	4575_UP
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	HDAC11 SEMA7A LMF2 SEMA6D ZMIZ2 ZFHX2 CBX8	2.73e-04	194	147	7	3977_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HG-U133A	FLNB EMC1 PLXNB2 LMF2 CIZ1 BSCL2 FH	2.73e-04	194	147	7	1884_DN
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	GRK4 YARS2 LIPE NFKBIB SLC17A7 ZFHX2 SAMD4A	2.73e-04	194	147	7	3680_UP
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A	B3GNT4 SLC48A1 IFNAR2 LMF2 ELK1 ABCC2 OSGIN1	2.73e-04	194	147	7	4967_UP
Drug	Nystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A	ADGRB2 SLC5A2 ZMIZ2 NFKBIB AGXT SLC17A7 SAMD4A	2.73e-04	194	147	7	4223_UP
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	RAD52 B3GNT4 SPEG ADGRB2 BCAN NFKBIB CBX8	2.73e-04	194	147	7	4492_DN
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	HDAC11 RBM4B BCAN SLC48A1 NFKBIB PLCG2 OSGIN1	2.73e-04	194	147	7	2900_DN
Drug	Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A	RAD52 NPR1 SPEG GRK5 SLC48A1 CRMP1 NFKBIB	2.73e-04	194	147	7	3345_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A	GALK1 MAOA NEBL SPEG SLC48A1 ZMIZ2 ELK1	2.81e-04	195	147	7	3714_DN
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	EMC1 GRK5 ITGA10 SLC48A1 CRMP1 LMF2 PLCG2	2.81e-04	195	147	7	2795_UP
Drug	Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A	DCAF1 NPR1 MAOA CRMP1 FARP2 AGO4 CIZ1	2.81e-04	195	147	7	2868_UP
Drug	Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A	RAD52 NEBL CARMIL1 ESRP1 ZMIZ2 LRP5 LTBP1	2.81e-04	195	147	7	3078_UP
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A_EA	B4GALT2 RAD52 TNK1 GRK5 KLHL18 CBX8 SAMD4A	2.81e-04	195	147	7	1015_UP
Drug	(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A	RAD52 HDAC11 SEMA7A SLC48A1 CRMP1 NFKBIB CIZ1	2.81e-04	195	147	7	3806_DN
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; HL60; HT_HG-U133A	MAOA SPEG LRRC49 BCAN SLC48A1 ZFHX2 SLC25A23	2.81e-04	195	147	7	2907_UP
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	NPR2 SLC4A8 GRK5 ADGRB2 SLC48A1 SLC5A2 SLC25A23	2.81e-04	195	147	7	5103_DN
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	B3GNT4 MAOA ZMIZ2 TMPRSS3 SLC17A7 SAMD4A OSGIN1	2.81e-04	195	147	7	6808_UP
Drug	oxypertine	VTN VWF ITGA10 ITGAV	2.82e-04	49	147	4	CID000004640
Drug	Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A	DCAF1 MAOA ADAM23 SLC48A1 LLGL1 ZFHX2 SAMD4A	2.90e-04	196	147	7	5000_UP
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; PC3; HT_HG-U133A	B3GNT4 HDAC11 NPR2 BCAN NEB ZMIZ2 NFKBIB	2.90e-04	196	147	7	4472_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HG-U133A	SLC48A1 LLGL1 ZFHX2 ELK1 DHTKD1 CBX8 SAMD4A	2.90e-04	196	147	7	492_DN
Drug	Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; HL60; HT_HG-U133A	SLC37A1 EMC1 SLC4A8 MAOA CRMP1 CEP170B ALG13	2.90e-04	196	147	7	2988_UP
Drug	Phenacetin [62-44-2]; Up 200; 22.4uM; PC3; HT_HG-U133A	NPR1 ADAM23 NEB LLGL1 ZMIZ2 NFKBIB ABCC2	2.90e-04	196	147	7	3992_UP
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A	GABRD NPR1 SEMA7A PAK6 CIZ1 PKP2 SNRNP200	2.90e-04	196	147	7	2762_UP
Drug	STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A	SEMA7A ADAM23 ADGRB2 BCAN FAAH SLC5A2 OSGIN1	2.90e-04	196	147	7	6380_UP
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A	HDAC11 LMF2 ZMIZ2 NFKBIB SLC17A7 SLC25A23 SAMD4A	2.90e-04	196	147	7	7335_UP
Drug	Proxyphylline [603-00-9]; Up 200; 16.8uM; HL60; HT_HG-U133A	NEBL ADAM23 FAAH ZMIZ2 NFKBIB SLC17A7 ELK1	2.90e-04	196	147	7	3115_UP
Drug	Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	DCAF1 HDAC11 GALK1 MAOA ZMIZ2 TMPRSS3 ZFHX2	2.90e-04	196	147	7	6483_DN
Drug	Calciferol [50-14-6]; Up 200; 10uM; HL60; HT_HG-U133A	GRK5 CRMP1 AGXT ZFHX2 ELK1 SNRNP200 SAMD4A	2.90e-04	196	147	7	2442_UP
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A	RAD52 ADAM23 BCAN AGO4 TBR1 KLHL18 SAMD4A	2.90e-04	196	147	7	3668_UP
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A	B3GNT4 SLC48A1 CRMP1 ZMIZ2 CIZ1 SLC25A23 CNN1	2.99e-04	197	147	7	2888_UP
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A	RAD52 NPR1 SPEG PAK6 SLC17A7 ZFHX2 CNN1	2.99e-04	197	147	7	3540_UP
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; HL60; HT_HG-U133A	RAD52 GALK1 NEBL FARP2 SLC17A7 LTBP1 KLHL18	2.99e-04	197	147	7	3085_UP
Drug	Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; HL60; HT_HG-U133A	RAD52 NEBL ZMIZ2 NFKBIB SLC17A7 LRP5 LTBP1	2.99e-04	197	147	7	3098_UP
Drug	Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A	RAD52 B3GNT4 SEMA7A FARP2 SEMA6D SLC17A7 SLC25A23	2.99e-04	197	147	7	6830_UP
Drug	Podophyllotoxin [518-28-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RAD52 ADAM23 CRMP1 FARP2 ZMIZ2 NFKBIB ELK1	2.99e-04	197	147	7	6103_DN
Drug	Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A	RAD52 B3GNT4 SLC5A2 FARP2 ELK1 TBR1 CBX8	2.99e-04	197	147	7	5668_DN
Drug	Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	SLC4A8 COL17A1 GRK5 NEB ZMIZ2 CBX8 SAMD4A	2.99e-04	197	147	7	3463_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A	GABRD RAD52 NPR1 MAOA GRK4 PAK6 PKP2	2.99e-04	197	147	7	4382_DN
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A	B4GALT2 SLC37A1 TNK1 GALK1 NEB SLC48A1 CIZ1	2.99e-04	197	147	7	6455_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A	RAD52 SPEG ADGRB2 BCAN NFKBIB SLC17A7 CNN1	2.99e-04	197	147	7	2248_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A	NPR1 ADGRB2 LLGL1 TMPRSS3 SLC17A7 CNN1 SAMD4A	2.99e-04	197	147	7	3801_UP
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A	NEBL SEMA7A ADAM23 GRK5 ADGRB2 ZMIZ2 ABCC2	2.99e-04	197	147	7	5076_UP
Drug	Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A	GABRD RAD52 NPR2 LLGL1 TMPRSS3 SNRNP200 SAMD4A	2.99e-04	197	147	7	3076_UP
Disease	response to radiation, breast carcinoma	NEBL SEMA6D TAGLN	1.83e-05	11	144	3	EFO_0000305, GO_0009314
Disease	congenital disorder of glycosylation Iw (implicated_via_orthology)	STT3A STT3B	2.37e-05	2	144	2	DOID:0080572 (implicated_via_orthology)
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	VWF GRK5 PLCG2	1.42e-04	21	144	3	EFO_0004286, EFO_0004792
Disease	venous thromboembolism, tissue plasminogen activator measurement	VWF GRK5 PLCG2	1.88e-04	23	144	3	EFO_0004286, EFO_0004791
Disease	venous thromboembolism, fibrinogen measurement	DIP2B VWF GRK5 PLCG2	3.28e-04	67	144	4	EFO_0004286, EFO_0004623
Disease	protocadherin-10 measurement	VTN SLC48A1	3.50e-04	6	144	2	EFO_0801978
Disease	age at diagnosis, substance-related disorder	BIRC6 SEMA6D	3.50e-04	6	144	2	EFO_0004918, MONDO_0002494
Disease	solute carrier family 35 member G2 measurement	VTN SLC48A1	3.50e-04	6	144	2	EFO_0802080
Disease	factor XI measurement, venous thromboembolism	VWF GRK5 PLCG2	4.20e-04	30	144	3	EFO_0004286, EFO_0004694
Disease	sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) measurement	VTN SLC48A1	4.89e-04	7	144	2	EFO_0803304
Disease	factor VIII measurement, venous thromboembolism	VWF GRK5 PLCG2	6.10e-04	34	144	3	EFO_0004286, EFO_0004630
Disease	reticulocyte count	RAD52 FLNB KLHL10 SLC25A20 VWF SLC48A1 PLXNB2 BIRC6 P2RY2 MAPKAPK3 LRP5 PLCG2 FBXO34 NOTCH4	6.17e-04	1045	144	14	EFO_0007986
Disease	E3 ubiquitin-protein ligase RNF13 measurement	VTN SLC48A1	6.50e-04	8	144	2	EFO_0801556
Disease	CD27 antigen measurement	VTN SLC48A1	6.50e-04	8	144	2	EFO_0008078
Disease	venous thromboembolism, factor VII measurement	VWF GRK5 PLCG2	8.47e-04	38	144	3	EFO_0004286, EFO_0004619
Disease	thioredoxin domain-containing protein 12 measurement	DCAF1 MST1 KLHL18	9.15e-04	39	144	3	EFO_0008298
Disease	response to carboplatin, response to antineoplastic agent	FLNB PLCG2	1.04e-03	10	144	2	GO_0097327, GO_0097328
Disease	diverticular disease	YARS2 GPR158 TMPRSS3 PKP2 LTBP1 DHTKD1	1.09e-03	236	144	6	EFO_0009959
Disease	venous thromboembolism, von Willebrand factor measurement	VWF GRK5 PLCG2	1.14e-03	42	144	3	EFO_0004286, EFO_0004629
Disease	gastrin-releasing peptide measurement	VTN SLC48A1	1.26e-03	11	144	2	EFO_0022000
Disease	persulfide dioxygenase ETHE1, mitochondrial measurement	VTN SLC48A1	1.51e-03	12	144	2	EFO_0008258
Disease	Huntington Disease, Late Onset	MAOA FAAH	1.51e-03	12	144	2	C0393574
Disease	Akinetic-Rigid Variant of Huntington Disease	MAOA FAAH	1.51e-03	12	144	2	C0751207
Disease	Juvenile Huntington Disease	MAOA FAAH	1.51e-03	12	144	2	C0751208
Disease	transmembrane protein 87B measurement	VTN SLC48A1	1.78e-03	13	144	2	EFO_0802158
Disease	reticulocyte measurement	RAD52 FLNB KLHL10 SLC25A20 VWF SLC48A1 PLXNB2 BIRC6 DNAJA3 P2RY2 LRP5 PLCG2 FBXO34	2.00e-03	1053	144	13	EFO_0010700
Disease	IGFBP-3 measurement	GRK5 PAK6 NOTCH4	2.35e-03	54	144	3	EFO_0004626
Disease	semaphorin-3A measurement	VTN SLC48A1	2.38e-03	15	144	2	EFO_0008278
Disease	Huntington Disease	MAOA FAAH	3.07e-03	17	144	2	C0020179
Disease	essential hypertension (is_implicated_in)	NPR2 GRK4	3.44e-03	18	144	2	DOID:10825 (is_implicated_in)
Disease	Disorder of organic acid metabolism	BCKDHA MCCC1	3.44e-03	18	144	2	cv:C1263739

Protein segments in the cluster

Peptide	Gene	Start	Entry
YMVLPRRTLSLQPGG	ADGRB2	1351	O60241
LTGRYPIRSGMVSSG	ARSF	86	P54793
RQGLLQGMAYTVQGP	COL17A1	1386	Q9UMD9
VQRENPGVLMGGRYT	B4GALT2	121	O60909
GPGGLARSSRNEYMR	ELK1	141	P19419
QGRGYGMPRNSSRFI	ALG13	651	Q9NP73
TRGVGVNEYGLPMAV	ADAM23	411	O75077
IQYQMDRGRRVSGGL	CYP27C1	311	Q4G0S4
GRYPVRSGMVSSIGY	ARSL	96	P51690
GVGPGRSVDRSLMYS	BIRC6	271	Q9NR09
GDGVYAGRPLSVIQM	FBXO34	196	Q9NWN3
GRRVPILMVTSGGYQ	HDAC11	291	Q96DB2
MSGRGTLGRNTPYKT	ABI1	186	Q8IZP0
GADPLIGTMYRNGIS	BTBD11	711	A6QL63
AYMVVSGLPGRNGQR	NPR2	911	P20594
APMLQYGGRNRTVAT	AGO3	416	Q9H9G7
TGRVLPAPMLQYGGR	AGO4	401	Q9HCK5
AYMVVSGLPVRNGRL	NPR1	926	P16066
PARDGVYVSANGRMV	CEP170B	831	Q9Y4F5
YSGITDVIIGMPHRG	DHTKD1	211	Q96HY7
AMSGLVRAPGVYVGT	BFSP2	46	Q13515
PGTVVRMQGLAYNTG	ESRP1	631	Q6NXG1
KSTMTLGRSGGRLPY	ERC1	86	Q8IUD2
LGRSGGRLPYGVRMT	ERC1	91	Q8IUD2
RLGPEYISSRMAGGG	RAD52	46	P43351
IIFSGGMPRASYGDR	LLGL1	306	Q15334
FPPGIMTQYGRVIRQ	MAOA	411	P21397
SRGAIYSIPIMEDGG	BCAN	401	Q96GW7
MFGFQRRGLGTPRLQ	PCDHA11	1	Q9Y5I1
MNAVIAYSIIGRRGP	PCDH20	776	Q8N6Y1
QPLRTYSTGLLGGAM	DCAF1	141	Q9Y4B6
VRGSAMPVDGYISGL	PAK6	71	Q9NQU5
LSDRVYVMGGSQLGP	KLHL31	511	Q9H511
YVMGGSQLGPRGERV	KLHL31	516	Q9H511
SPGMKRRIRLGQYGF	MAPKAPK3	251	Q16644
RMKPDIVTYGAGVRG	MBTPS1	386	Q14703
LMLGGGGYTIRNVAR	HDAC1	296	Q13547
LSRTAQRIPYMTGGR	GPR158	511	Q5T848
GSLYPTSMRIGDEGR	FREM2	2726	Q5SZK8
VSLMGGRGGVPLYDR	LRP5	1461	O75197
LRAGANPAARMYGGR	NFKBIB	261	Q15653
KARAYGRGIEPTGNM	FLNB	256	O75369
AGLAPLGEYRLLGRM	MOAP1	41	Q96BY2
RGQMLLEVSYGGSPV	PLXNB2	956	O15031
KGVGMRLSRAGPSYA	FAT2	4296	Q9NYQ8
MSQPSGGRAPGTRIY	LGALS12	1	Q96DT0
GGMGYTVSGVHRRRP	LTBP1	731	Q14766
PRRGLSGYSMLAIGI	NDUFA13	26	Q9P0J0
AALAVPGVYGSRMTG	GALK1	331	P51570
LPGRAILSMNGLSYG	DIP2B	691	Q9P265
MIPGKYRSVSGRAAN	LRRC49	1	Q8IUZ0
EGITGLYRGMAAPII	SLC25A20	66	O43772
RRVPGNLMGSYRSVG	GABRD	381	O14764
PASQRDMRVGVYGAL	ABCC2	1016	Q92887
NGRTGYVLQPESMRT	PLCG2	1031	P16885
VYGTLGGMLTRQPFA	PSMB9	131	P28065
EMGLQGLYIGSSPER	HSPA12B	6	Q96MM6
LRRAAAMLPTVGEGY	RBM4B	306	Q9BQ04
MARRLLKPAYGTSGG	P2RY2	221	P41231
APMSKRRGGVGVATY	KLHL4	601	Q9C0H6
VVYRQPGTAAMGGLA	SLC48A1	31	Q6P1K1
GYTMHGLTVRPLGQA	IFNAR2	336	P48551
GMGRGLLNYPRVREL	MCAT	76	Q8IVS2
VLGDPGTRMLRGYRG	PXDNL	1021	A1KZ92
GTRMLRGYRGYNPNV	PXDNL	1026	A1KZ92
AVGMYLSGIIGERLP	SLC37A1	111	P57057
SSGISGSQRRYIGVM	HTRA2	351	O43464
MRSRRSGIGVIAYGE	KLHL10	466	Q6JEL2
PSRGYGVMEEIRRQG	KLHL18	21	O94889
YRDMGAQGGRPSLIA	CBX8	321	Q9HC52
AGGGGYVMSRATVRR	B3GNT4	276	Q9C0J1
MAGGSPAAKRVVVYR	DCDC2B	1	A2VCK2
NSRGGYDSGPRMTRR	DYTN	136	A2CJ06
MPRIYELAAGGTAVG	FH	266	P07954
SGVPRAARTLGMVYI	ITGAV	271	P06756
MGLTAYGNRRVQPGE	ADGRF2	1	Q8IZF7
VFITMNPRYGGGVEL	DNAH14	1236	Q0VDD8
RRIGYPVMIKAVRGG	MCCC1	196	Q96RQ3
LGYSVSSMLLRGGRR	ITGA10	431	O75578
SPQAGRRYGVQVMGS	CARMIL1	1151	Q5VZK9
VSRMRGIYTAPSGLE	EMC1	916	Q8N766
YGQEAVRLSVGPMAR	FAAH	271	O00519
ISGPDGYRRDLMTAG	FCRL2	386	Q96LA5
VGYRGTMATTVGGLP	MST1	116	P26927
QRVRGRVGTVGYMAP	GRK4	341	P32298
LIRGRVGTVGYMAPE	GRK5	341	P34947
GTYRVLQTAGMRLGA	FARP2	6	O94887
LTKGGRDRVLMYGQP	BSCL2	91	Q96G97
IRMGGKGIPRINSYG	DNAJA3	386	Q96EY1
SVYGARLMVPAGQGL	DHRS1	131	Q96LJ7
MPTRGRTVAGILLGY	SLC22A20P	216	A6NK97
MLTDPYGSQARLGVR	PRRT3	521	Q5FWE3
NGRMVIPGGIDVNTY	CRMP1	61	Q14194
INLMIGSTRYGDGPR	DHX9	1146	Q08211
LRAAAYGVRVPDGIM	LIPE	736	Q05469
STRQEGLYAMGPLAG	OSGIN1	436	Q9UJX0
ARGPGYGIMSIRVDG	BCKDHA	286	P12694
RDGMEGLVPVGYTSL	RUSC1	886	Q9BVN2
GTYRAGPMRQISLVG	RSBN1L	456	Q6PCB5
ASLGGTPLYMDRQGI	AGXT	186	P21549
MAEVGRTGISYPGAL	TRMT44	1	Q8IYL2
TKIYGGRQRNGVMPS	RPS19	76	P39019
VGRARGFLPYVGMVT	SEC11C	151	Q9BY50
RSQIVPGARYAMAGS	TBR1	416	Q16650
PTRGQLEGRMIVTAY	TADA1	146	Q96BN2
SYGLFRRMTGLGGRP	LMF2	451	Q9BU23
DGPRGYRMITEGGVS	YARS2	421	Q9Y2Z4
QQPYLEGSTVMRGTR	TDRD10	236	Q5VZ19
YVRALNMGGPSVRSE	FSD2	541	A1L4K1
REKRPYGLGMVGRLT	RHBDF1	366	Q96CC6
GRIIGGTIYPGLMIT	STT3A	81	P46977
VSRQGTVAGYGMVAR	SETD6	66	Q8TBK2
ALRRPGTGGGYRMEA	SHISA7	351	A6NL88
PRYASILMGISNGVG	SLC17A7	431	Q9P2U7
SQAGMTGYGRPRQII	TAGLN	186	Q01995
RRRMQTAGVTGYPRA	SLC25A42	251	Q86VD7
RTLYVGVRMPLGRQS	SLC4A8	46	Q2Y0W8
NPAIMRGRYGVAAGR	NOTCH4	1926	Q99466
MVAPVTGYSLGVRRA	SDCBP2	86	Q9H190
LNMIQVPYRAVSGPG	CLRN2	121	A0PK11
GLTMPTATLGNLRGY	CIZ1	111	Q9ULV3
KGASQRGMTVYGLPR	CNN1	251	P51911
RGYSSRIVGGNMSLL	TMPRSS3	211	P57727
GLPRRYIIAIMSGLG	SLC17A6	66	Q9P2U8
YLPTRGGTTMASGGR	TRIM55	61	Q9BYV6
GTGVPDGMGQRRYRT	ZFHX2	2056	Q9C0A1
GRLVSVPYVGGNMEV	VWF	2026	P04275
GAPVNMYSRRAAGTR	SEC16A	2176	O15027
GAGVLTYIMLSGRSP	SPEG	3146	Q15772
GVITMPQYLRKRFGG	SLC5A2	121	P31639
RIVGGTVYPGLMITA	STT3B	136	Q8TCJ2
RLIYGSGLLGMQSGR	WDR97	871	A6NE52
GQGRYPVGVSNMVLR	RFX8	501	Q6ZV50
QLGRVVVGPYMYTRG	SYT15B	431	X6R8R1
GQSPRRGTVMYVGLT	TBCB	171	Q99426
GARESAPYRGMVRTA	SLC25A27	61	O95847
VNGTVVPLGEMRGYA	SEMA7A	156	O75326
GQTPYLMDQLGLRLG	PPP1R36	16	Q96LQ0
GTGVNVYLMKRSPRG	PBK	41	Q96KB5
RRLSPVAIMGNGYVD	PKHD1L1	3781	Q86WI1
PTRAAGMTPLYAGQR	ZMIZ2	231	Q8NF64
QMLGRAGRPQYDTKG	SNRNP200	851	O75643
LVRPLGGARGRYVMG	TNK1	266	Q13470
LSQEGMRGLYRGIAP	SLC25A23	426	Q9BV35
GSFRRPGTMTLQDGR	SH3RF2	86	Q8TEC5
MNYTGRIGAIGRTNL	SLC27A6	371	Q9Y2P4
GVLLSRQPSMNRGGY	SEMA6D	986	Q8NFY4
PQLRNVGGVRAIPYM	UBR4	2986	Q5T4S7
AGRIYISGMAPRPSL	VTN	351	P04004
LTYPRPGTSRSMGNL	PKP2	241	Q99959
SVGGGMGRRNPRQYQ	SAMD4A	586	Q9UPU9
VQRTGRTGMLPANYI	NEBL	996	O76041
TVQRTGRTGMLPANY	NEB	6651	P20929